Sirio Pharma's latest marketcap:
As of 06/23/2025, Sirio Pharma's market capitalization has reached $1.04 B. According to our data, Sirio Pharma is the 9124th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.04 B |
| Revenue (ttm) | 586.56 M |
| Net Income (ttm) | 46.03 M |
| Shares Out | 306.4 M |
| EPS (ttm) | 0.15 |
| Forward PE | 19.04 |
| Ex-Dividend Date | 05/27/2025 |
| Earnings Date | 08/12/2025 |
Sirio Pharma's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/23/2025 | ¥1.04 B | 21.39% | 9124 |
| 12/31/2024 | ¥6.17 B | -2.01% | 9721 |
| 12/29/2023 | ¥6.29 B | -5.18% | 9352 |
| 12/30/2022 | ¥6.64 B | -11.66% | 8444 |
| 12/31/2021 | ¥7.51 B | -31.92% | 8464 |
| 12/31/2020 | ¥11.04 B | 123.46% | 5905 |
| 12/31/2019 | ¥4.94 B | 8333 |
Company Profile
About Sirio Pharma Co., Ltd.
Sirio Pharma Co., Ltd. is a global contract manufacturer specializing in dietary supplements and nutraceutical products. Established in 1993 and headquartered in Shantou, China, the company serves clients worldwide with innovative and high-quality solutions.
Product Offerings
- Softgel Dietary Supplements – Custom formulations for various health needs.
- Vegetarian Softgels – Plant-based alternatives for specialized diets.
- Nutraceutical Gummies – Tasty and functional supplement options.
- Probiotic Products – Supporting digestive and immune health.
- Tablets & Powders – Versatile formats for easy consumption.
- Capsules – Precision-dosed supplements in convenient forms.
- Functional Beverages – Enhanced drinks for targeted wellness benefits.
Additional Services
Sirio Pharma also provides comprehensive packaging solutions, including primary and final packaging, ensuring product integrity and market-ready presentation.
Frequently Asked Questions
-
What is Sirio Pharma's (SHE-300791) current market cap?As of 06/23/2025, Sirio Pharma (including the parent company, if applicable) has an estimated market capitalization of $1.04 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sirio Pharma (SHE-300791) rank globally by market cap?Sirio Pharma global market capitalization ranking is approximately 9124 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.